54 related articles for article (PubMed ID: 16978775)
1. Lower levels of cerebrospinal fluid amyloid beta (Abeta) in non-demented Indian controls.
Subramanian S; Sandhyarani B; Shree AN; Murthy KK; Kalyani K; Kumar SP; Pradeep ; Noone MJ; Taly AB
Neurosci Lett; 2006 Oct; 407(2):121-3. PubMed ID: 16978775
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides.
Bibl M; Esselmann H; Otto M; Lewczuk P; Cepek L; Rüther E; Kornhuber J; Wiltfang J
Electrophoresis; 2004 Sep; 25(17):2912-8. PubMed ID: 15349929
[TBL] [Abstract][Full Text] [Related]
3. An age-related correlation between levels of beta-amyloid precursor protein and beta-amyloid in human cerebrospinal fluid.
Carroll RT; Lust MR; Kim KS; Doyle PD; Emmerling MR
Biochem Biophys Res Commun; 1995 May; 210(2):345-9. PubMed ID: 7755609
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.
Fagan AM; Roe CM; Xiong C; Mintun MA; Morris JC; Holtzman DM
Arch Neurol; 2007 Mar; 64(3):343-9. PubMed ID: 17210801
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
[TBL] [Abstract][Full Text] [Related]
6. An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid.
Portelius E; Zetterberg H; Andreasson U; Brinkmalm G; Andreasen N; Wallin A; Westman-Brinkmalm A; Blennow K
Neurosci Lett; 2006 Dec; 409(3):215-9. PubMed ID: 17049739
[TBL] [Abstract][Full Text] [Related]
7. Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.
Bibl M; Mollenhauer B; Lewczuk P; Esselmann H; Wolf S; Trenkwalder C; Otto M; Stiens G; Rüther E; Kornhuber J; Wiltfang J
Mol Psychiatry; 2007 Jul; 12(7):671-80. PubMed ID: 17339876
[TBL] [Abstract][Full Text] [Related]
8. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
9. Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods.
Simonsen AH; Hansson SF; Ruetschi U; McGuire J; Podust VN; Davies HA; Mehta P; Waldemar G; Zetterberg H; Andreasen N; Wallin A; Blennow K
Dement Geriatr Cogn Disord; 2007; 23(4):246-50. PubMed ID: 17310122
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry.
Gelfanova V; Higgs RE; Dean RA; Holtzman DM; Farlow MR; Siemers ER; Boodhoo A; Qian YW; He X; Jin Z; Fisher DL; Cox KL; Hale JE
Brief Funct Genomic Proteomic; 2007 Jun; 6(2):149-58. PubMed ID: 17584762
[TBL] [Abstract][Full Text] [Related]
11. A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease.
Verwey NA; van der Flier WM; Blennow K; Clark C; Sokolow S; De Deyn PP; Galasko D; Hampel H; Hartmann T; Kapaki E; Lannfelt L; Mehta PD; Parnetti L; Petzold A; Pirttila T; Saleh L; Skinningsrud A; Swieten JC; Verbeek MM; Wiltfang J; Younkin S; Scheltens P; Blankenstein MA
Ann Clin Biochem; 2009 May; 46(Pt 3):235-40. PubMed ID: 19342441
[TBL] [Abstract][Full Text] [Related]
12. Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals.
Galasko DR; Graff-Radford N; May S; Hendrix S; Cottrell BA; Sagi SA; Mather G; Laughlin M; Zavitz KH; Swabb E; Golde TE; Murphy MP; Koo EH
Alzheimer Dis Assoc Disord; 2007; 21(4):292-9. PubMed ID: 18090435
[TBL] [Abstract][Full Text] [Related]
13. Increase in beta-amyloid levels in cerebrospinal fluid of children with Down syndrome.
Englund H; Annerén G; Gustafsson J; Wester U; Wiltfang J; Lannfelt L; Blennow K; Höglund K
Dement Geriatr Cogn Disord; 2007; 24(5):369-74. PubMed ID: 17914261
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.
Höglund K; Hansson O; Buchhave P; Zetterberg H; Lewczuk P; Londos E; Blennow K; Minthon L; Wiltfang J
Neurodegener Dis; 2008; 5(5):268-76. PubMed ID: 18309230
[TBL] [Abstract][Full Text] [Related]
16. Plasma Abeta levels do not reflect brain Abeta levels.
Freeman SH; Raju S; Hyman BT; Frosch MP; Irizarry MC
J Neuropathol Exp Neurol; 2007 Apr; 66(4):264-71. PubMed ID: 17413317
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.
Hellström-Lindahl E; Ravid R; Nordberg A
Neurobiol Aging; 2008 Feb; 29(2):210-21. PubMed ID: 17098332
[TBL] [Abstract][Full Text] [Related]
18. The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels.
Abdullah L; Paris D; Luis C; Quadros A; Parrish J; Valdes L; Keegan AP; Mathura V; Crawford F; Mullan M
Neurosci Lett; 2007 Nov; 428(2-3):53-8. PubMed ID: 17964720
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.
Portelius E; Brinkmalm G; Tran AJ; Zetterberg H; Westman-Brinkmalm A; Blennow K
Neurodegener Dis; 2009; 6(3):87-94. PubMed ID: 19229112
[TBL] [Abstract][Full Text] [Related]
20. Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.
Valis M; Talab R; Stourac P; Andrys C; Masopust J
Neuro Endocrinol Lett; 2008 Dec; 29(6):971-6. PubMed ID: 19112391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
